Related Experiment Video
Updated: Jun 8, 2026
06:09
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
B-RAF: A contributor to the melanoma phenotype
E M L Heath1, K L Kaufman, R I Christopherson
1Cancer Proteomics Laboratory, School of Molecular Bioscience, G08, The University of Sydney, NSW, 2006, Australia.
The International Journal of Biochemistry & Cell Biology
|October 2, 2010
Summary
Mutated BRAF (B-RAF) drives melanoma but direct inhibition is ineffective. New strategies are needed to target B-RAF-induced melanomas due to pathway complexity.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- B-RAF is a key serine-threonine protein kinase in the RAS-RAF-MEK-ERK signaling pathway.
- Mutated B-RAF is implicated in melanoma development, progression, and malignant phenotype.
- B-RAF mutations are common in melanocytic lesions and persist throughout melanoma progression.
Purpose of the Study:
- To investigate the role of B-RAF in melanoma.
- To explore challenges in targeting B-RAF for melanoma treatment.
- To advocate for alternative therapeutic strategies against oncogenic B-RAF melanomas.
Main Methods:
- Analysis of B-RAF's role in the RAS-RAF-MEK-ERK pathway.
- Review of clinical data on B-RAF inhibition in melanoma.
- Exploration of melanoma pathogenesis and therapeutic resistance.
Main Results:
- B-RAF mutations are prevalent and critical in melanoma.
- Direct B-RAF inhibition shows limited clinical success in melanoma treatment.
- The complexity of the RAS-RAF-MEK-ERK pathway hinders direct inhibition efficacy.
Conclusions:
- Alternative strategies are essential for treating B-RAF-driven melanomas.
- Understanding pathway complexity is crucial for developing new therapies.
- Targeting oncogenic B-RAF melanomas requires innovative approaches beyond direct inhibition.
More Related Videos
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Related Concept Videos
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...